A Decade Strong — Celebrating 10 Years of BMWS
As one of the world’s largest manufacturers of biopharmaceuticals, we leverage our in-depth industry experience for collaborating with top pharma and biotech companies.
Our contract manufacturing business Boehringer Ingelheim BioXcellence™ is built on profound experience in key technologies – mammalian and microbial derived biopharmaceuticals – and supported by a global manufacturing network ranging from US via Europe to Asia that handles the entire production chain, from DNA to aseptic filling. Our track record in commercial and clinical supply is impressive – since initiating contract manufacturing in 1998, we’ve successfully brought 49 biologics to market. Furthermore, we transferred and optimized over 150 development and manufacturing projects focusing on late stage and commercial supply.
We collaborate with partners worldwide, offering capabilities that complement their expertise. Together we turn biologic innovation into commercial success.
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’ proprietary platform—the Cell Shuttle—biopharma companies, academic research centers, and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, Calif.
In April 2019, Emerson acquired Bioproduction Group (Bio-G), a leader in simulation, modeling, and scheduling software for biomanufacturing. Bio-G’s scheduling and modeling systems combined with Emerson’s extensive life sciences technology and expertise portfolio will help companies bring therapies for cancer, diabetes, and other illnesses to patients sooner.
Life sciences companies continually look to accelerate the production of patient therapies and the Bio-G Scheduling software helps them accurately predict future plant resource availability to optimize manufacturing production. The scheduling software delivers an instantaneous view, accessible across an organization, into the current and future state of the plant, providing decision support to help increase facility uptime and reduce schedule-related product losses.
Project Farma is an industry leader in providing project management, validation, engineering and consulting services with a proven track record in gene and cell therapy. We partner with gene and cell therapy organizations in addition to healthcare, pharmaceutical, bio-pharmaceutical companies to support finding ground-breaking treatments and solutions. Our gene and cell therapy clients include early stage startups, establish cell and gene therapy companies and CMOs / CROs. We are committed to helping advance cutting-edge medicines by leveraging our deep knowledge and broad experience in cell and gene therapy to meet any new challenges.
ScaleReady is transforming how cell and gene-modified cell therapies (CGTs) are manufactured. Centered on G-Rex® technology, ScaleReady delivers a lean, high-throughput manufacturing platform that is practical, flexible, scalable, and cost-efficient. CGT entities relying on the breadth and scope of ScaleReady’s expertise can expect to save years of time and millions of dollars on the path to CGT commercialization.
Today, G-Rex is used in ~50% of relevant CGT trials and supports 5 commercially approved therapies, including the industry’s most commercially successful cell therapy. The G-Rex Centric™ Platform is the only manufacturing system capable of meeting patient demand and market scale, giving developers a clear path from process development to profitable commercialization.
Novartis Contract Manufacturing is a global CDMO with over 40 years of GMP experience in biotech, small molecules, cell & gene therapy, and fill & finish. With a proven track record of quality, reliability and global manufacturing network, we are committed to delivering tailored solutions that meet the unique needs of our clients, building long-lasting CDMO partnerships based on trust and excellence.
Vision. Expertise. Success.
AbbVie Contract Manufacturing partners with companies across the globe to develop, scale and manufacture pharmaceutical products and bring them successfully to market.
Drawing on more than four decades of success as the manufacturing division of AbbVie, we have the depth of experience and the technical knowledge to navigate issues and deliver the innovative solutions customers need. We are much more than a CMO – we are your partner for success.
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Whatman and Xcellerex. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients.
DCI, Inc., founded in 1955 with its corporate offices in Saint Cloud, MN, is a world leading manufacturer of stainless-steel storage and processing vessels, agitators, and fully integrated, skidded systems for the hygienic industries, particularly pharmaceutical, biopharmaceutical, biotech, animal health and cosmetic industries. Vertically fully integrated, DCI’s portfolio of products and services includes tanks, pressure vessels, and skidded processing equipment with aseptic media, batch and mixing tanks, fermenters, bioreactors, horizontal and vertical storage tanks. In addition to our standard equipment, DCI also custom-engineers and fabricates skidded systems to fit your company needs and certifies your equipment to meet all your regulatory requirements. For more information, please visit www.dciinc.com.
Parsec Automation Corp. (Parsec) is the developer of TrakSYS™, the leading real-time operations & performance management software. Manufacturing companies worldwide rely on Parsec for flexible and configurable tools to execute manufacturing operations across the value stream more effectively.
BIB is a full service CDMO partner offering cGMP and non-GMP mammalian, microbial, gene therapy and cell therapy services.
Cognite is an AI company that delivers industrial software to improve production efficiency of Energy, Process Manufacturing, and other industrial companies.
We liberate siloed data and deliver AI-powered solutions that make data easier to find and use so process engineers, field workers, maintenance teams, and other data consumers can make the right decisions at the right time—empowering our customers to solve some of their most complex business problems.
We’re globally recognized domain experts with an international presence that spans from Oslo, Norway to Austin, Texas to Tokyo, Japan.
Honeywell Life Sciences, the makers of TrackWise, are on a mission to accelerate innovation for a healthier future. From manufacturing life-saving drugs to safeguarding supply chain continuity, Life Sciences organizations partner with Honeywell to solve their most critical challenges and drive meaningful patient and business outcomes. Honeywell empower Life Science companies with the latest innovation to improve operational efficiency and bring safer products to market faster, by automating and optimizing their manufacturing and supply chain eco-system. Life Sciences companies worldwide trust Honeywell for the advanced technology solutions and domain expertise they need to drive continuous business improvements while helping them make smarter faster decisions about the things that matter most.
Körber Pharma Software, formerly Werum IT Solutions, is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical, biotech and cell and gene therapy industries. Our out-of-the-box PAS-X software is run by the majority of the world’s top 30 pharmaceutical and biotech companies and by many mid-sized manufacturers. We offer a full-scope MES solution comprising the PAS-X software product and pre-configured content for pharmaceutical, biotech and cell & gene processes completed by consulting, training and support services. PAS-X is a mature standard software product with full functionality that can be implemented within a comparably short time.
Körber is an international technology group with about 13,000 employees, more than 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. At Körber Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions.
Russell Reynolds Associates is a global search and leadership advisory firm. Our 425+ consultants in 46 offices work with public, private and nonprofit organizations across all industries and regions. We help our clients build teams of transformational leaders who can meet today’s challenges and anticipate the digital, economic and political trends that are reshaping the global business environment. From helping boards with their structure, culture and effectiveness to identifying, assessing and defining the best leadership for organizations – our teams bring their decades of expertise to help clients solve their most complex leadership issues.
Yokogawa provides cutting-edge technologies and services in measurement, control, and information to customers across diverse industries including energy, chemicals, materials, pharmaceuticals, food, and water.
By leveraging digitally enabled smart manufacturing solutions, Yokogawa helps customers address the challenges of increasingly complex production, operations management, and optimization of assets, energy, and supply chains—ultimately supporting their transition toward autonomous operations.
Yokogawa’s Life Science Business began in 1996 with the development of innovative instruments based on proprietary confocal microscopy technology.
Since then, the company has been dedicated to delivering advanced microscopy, imaging, and analytical solutions that accelerate cell biology research, bioprocess development, and drug discovery.
APC helps biopharma companies slash drug development times by delivering breakthrough science at lightning-fast process development speed. We thrive on radical collaboration – challenging ourselves and our clients to deliver for patients faster. iAchieve, our proprietary, cloud-based knowledge management platform digitizes every aspect of your medicine’s journey from process definition through process characterization and into the manufacturing facility that best suits your needs.
Asimov is developing a synthetic biology platform – from cells to software – to enable better design and manufacture of next-generation therapeutics. Asimov’s CHO Edge System for biologic production minimizes the risk of cell line development by enabling exploration of vector design space – Asimov routinely achieve titers of 8–11 g/L across modalities.
Asimov is applying the same approach to improve cell & gene therapies – by developing stable lentiviral cell lines and a best-in-class AAV expression system, and enhancing safety profiles through the creation of synthetic tissue specific promoters.
Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 30 years of experience producing monoclonal antibodies and recombinant proteins, Avid’s services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization.
Grand River Aseptic Manufacturing (GRAM) is a leading contract development and manufacturing organization (CDMO) specializing in sterile injectable fill-and-finish services for liquid and lyophilized vials, syringes, and cartridges. We are committed to advancing patient care by providing our clients with the experience, technology, and quality record necessary for effective clinical trials and successful commercialization. GRAM adds value for our clients through strategic partnerships with innovators in drug delivery devices, offering tailored solutions designed for autoinjectors and on-body delivery systems. Our emphasis on collaboration allows us to speed up the delivery of innovative therapies, ensuring that our clients’ products reach the market and benefit patients into the future.
L7 Informatics reimagines data intelligence for modern life sciences and healthcare organizations. Beyond simple data management, L7 provides tools that optimize the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains. Our comprehensive operating environment and software stack bring flexible, secure, and collaborative data intelligence to your entire operation. From regulatory compliance and workflow orchestration to customized applications and integrations, our end-to-end transformation engine helps organizations solve today’s challenges and realize tomorrow’s opportunities. L7|ESP™ is designed to unlock innovation at every stage of the clinical, research, and manufacturing value chain. From data and workflow orchestration to custom apps and integrations, L7|ESP is an end-to-end transformation engine to help solve today’s challenges and realize tomorrow’s opportunities.
The L7 Manufacturing Execution System (MES) offers a unified platform approach to manufacturing operations management. While traditional MES is rigid and siloed from other systems and equipment, leaving operations still relying on forms and spreadsheets, L7 MES provides a holistic manufacturing operations management experience. Additionally, the L7 MES system is designed for developing and progressing seamlessly to CGMP production. We are CGMP-ready and provide the flexibility to support the early-stage process development, capturing and curating your data resource across your journey to clinical and commercial production.
PCI is your world leading CDMO, truly spanning the cycle, connecting development and commercialization, de-risking the supply chain providing clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products’ speed to market, and opportunities for commercial success.
PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. Leading technology and continued investment enable us to address global outsourcing development needs throughout the product lifecycle.
PCI offers a global network of innovative centers of excellence for the development, manufacturing, packaging, storage, and distribution of life changing therapies. Our specialist contained manufacturing and packaging facilities dedicated to processing highly potent drug products, combined with our renowned lyophilization and sterile manufacturing capabilities are complemented by a global network of packaging facilities delivering a true end-to-end service. Our aim is simple, to accelerate your product from development to commercialization as efficiently and cost-effectively as possible.
For over 25 years, ProPharma has partnered with biotech, pharmaceutical, and medical device organizations to bring groundbreaking therapies to market. Offering a fully customizable, end-to-end suite of services, we empower our clients to overcome regulatory complexities and deliver life-changing therapies to patients worldwide.
At ProPharma, we help pharmaceutical, biotechnology, and medical device companies bring life-changing therapies to market. From early development through clinical, regulatory approval, and commercialization, we provide expert guidance to navigate complex challenges and accelerate success.
Our mission is simple – improving patient health and safety by delivering the highest quality regulatory, compliance, clinical research, pharmacovigilance, and medical information services throughout the entire product lifecycle.
Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company aims to build a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely and at scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives.
Be LIFE SCIENCE READY –
Pharma 4.0 HMI systems for cleanroom environments
Systec & Solutions Group is a leading provider of high-quality hardware and software solutions, specializing in the development of innovative products for cleanroom environments and industries requiring strict compliance standards. The product portfolio includes state-of-the-art HMI systems, mobile IT workstations, control panels, and e-papers all designed to meet the specific needs of pharmaceutical, biotech, food, and other regulated industries.
With a solid foundation in Germany, Systec & Solutions Group has successfully expanded into international markets, especially the United States, where numerous projects have been completed to the highest standards. The products are known for their durability, precision, and user-friendly design, ensuring seamless integration into our clients’ operations.
To better serve the growing customer base in the US, Systec & Solutions Group has established a company site in Apex, North Carolina. This local presence allows Systec & Solutions to provide faster delivery times, superior customer support, and direct service and sales, further enhancing the experience for the American clients.
The US-based team oversee all sales, distribution, and service activities, ensuring that Systec & Solutions Group’s solutions are accessible and efficiently supported throughout the region. By focusing on quality, reliability, and innovation, Systec & Solutions continues to deliver outstanding results across the globe.
Teknova makes solutions possible. With fast access to high-quality off-the-shelf and custom plates, culture and cryopreservation media, buffers, reagents, and water, we accelerate breakthroughs in emerging therapies, molecular diagnostics, and synthetic biology. Our proprietary modular manufacturing platform enables a smooth transition from RUO to GMP, supporting discovery, development, and commercialization.
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services’ all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 674,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities.
Aragen Life Sciences is a globally renowned R&D and manufacturing solutions provider to the global life sciences industries. It offers a range of solutions across the drug discovery, development and manufacturing continuum to advance small and large-molecule programs. The Company operates through a global network of six sites with a team of ~4500 employees and 450+ PhDs. Its expertise and experience have enabled over 400 customers to advance their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Visit www.aragen.com for more details.
Leveraging Drosophila melanogaster to produce your difficult-to-express protein at scale. Tackling expression challenges, host-cell toxicity, large volume requirements, and cost efficiency, we help biotech/biopharma conserve budget and make great proteins, unlocking new products and workflows. The EntoEngine’s multicellular and tissue-specific expression services are especially suited for companies that require a bespoke approach to difficult-to-express proteins or low/no-yield proteins without sacrificing quality, sustainability, or affordability.
Honeywell Life Sciences, the makers of TrackWise, are on a mission to accelerate innovation for a healthier future. From manufacturing life-saving drugs to safeguarding supply chain continuity, Life Sciences organizations partner with Honeywell to solve their most critical challenges and drive meaningful patient and business outcomes. Honeywell empower Life Science companies with the latest innovation to improve operational efficiency and bring safer products to market faster, by automating and optimizing their manufacturing and supply chain eco-system. Life Sciences companies worldwide trust Honeywell for the advanced technology solutions and domain expertise they need to drive continuous business improvements while helping them make smarter faster decisions about the things that matter most.
IDA Ireland was founded in 1949 as the Irish Government agency responsible for the attraction and retention of foreign direct investment (FDI) into Ireland. IDA Ireland partners with multinational companies to attract investment, providing jobs for the economic and social benefit of Ireland.
We have partnered with 1,200 companies to establish operations in Ireland, including all the World’s Top 10 Biopharmaceutical companies.
The biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities in Ireland, most of which has come in the last 10 years. This represents the biggest wave of investment in new biotech facilities anywhere in the world.
Speak with us and you will soon understand why Ireland has developed Europe’s premier biopharma manufacturing cluster.
OrganaBio is a leading provider of high-quality cellular raw materials and support services for the development of cell and gene therapies. We specialize in sourcing, isolating, and delivering fresh, consistent, and ethically sourced human cells – including leukopaks, PBMCs, and immune cells – to power preclinical research and clinical trials.
Our mission is to accelerate breakthroughs in regenerative medicine by providing researchers and biotech partners with the critical materials they need: quickly, reliably, and at scale. From early discovery through cGMP manufacturing, OrganaBio ensures that every sample meets the highest standards of quality, traceability, and ethical sourcing.
With a focus on innovation, speed, and partnership, OrganaBio empowers biotech and pharma teams to transform cutting-edge science into life-changing therapies.
Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.
Wheeler Bio is a biomanufacturing pioneer, founded by a team of industry experts and strategic investors who believed a streamlined CMC CDMO model is needed to help innovators accelerate the process between discovery and clinical studies.
As a High Science/High Touch biologics CDMO, we leverage our team’s collective experience on over 1,400 unique molecules as well as years of internal research and development to develop our Modular CMC platform. This streamlined approach to antibody and antibody-like biologic CMC development provides our clients with the speed and scalability needed to get programs into the clinic and beyond with unmatched budget and timeline security. Whether developing innovative biologics, biosimilars, or onshoring existing programs, our Modular CMC platform serves biotechs and large pharma alike.